explore -WSS

explore

author：knowledge 2025-10-02 21:05:47 - browse：2

Vertex Pharmaceuticals - sunset — Bill Sikes/AP

LONDON — Regulators in the U.K. on Thursday approved a CRISPR-based medicine to treat both sickle cell disease and beta thalassemia, making it the world’s first therapy built on the revolutionary gene-editing technology and ushering in a new era of genetic medicine.

The authorization of the therapy, from Vertex Pharmaceuticals and CRISPR Therapeutics, is itself not a surprise. Clinical trials have shown the one-time treatment enabled many sickle cell patients to live free of debilitating pain crises and relieved thalassemia patients of needing regular blood transfusions, raising hopes that they have been effectively cured. But it also stands as a major achievement, coming just over a decade after the first and seminal lab experiments that showed CRISPR’s potential as a gene-editing tool were published.

In granting conditional approval to the therapy, which will have the brand name Casgevy and is also known as exa-cel, the U.K.’s Medicines and Healthcare products Regulatory Agency jumped ahead of its counterparts in the U.S. and Europe, which are also reviewing the medicine, in greenlighting the globe’s first CRISPR treatment. The MHRA’s authorization is for patients who are at least 12 years old.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Dana Farber says 6 studies to be retracted and 31 corrected

WSS

CVS is on a mission to consolidate health care. Will it work?

Microsoft launches AI tool for clinical documentation through Epic

When is a doctor not a doctor? Try when patients address women doctors

Ukraine, Russia accuse each other of planning to attack Europe's biggest nuclear plant

Pfizer's Covid pill remains 89% effective in final analysis, company says

Why is France rioting? What to know about the fatal police shooting of Nahel M

Wikipedia

explore

explore

Tori Bowie and the unacceptable rates of Black maternal death

Did the public have the right to know Arthur Ashe had AIDS?

ChatGPT in medicine: STAT answers readers' burning questions

4th of July breaks record for highest global temperature ever measured

Medicare proposal to cover medical devices draws a mixed reaction

FDA sets aggressive timeline for overhauling inspection procedures

Wildfire smoke exposes gaps in outdoor worker protections

Medicare drug price lawsuits could be good politics for Biden

ChatGPT in medicine: STAT answers readers' burning questions

A new study asks: Are we harming blood donors by taking blood?

focus

Maisha Meds is a PBM, but don't call it that

Microsoft launches AI tool for clinical documentation through Epic

Future doctors need a strong humanities education

Make 'food is medicine' a key part of White House nutrition meeting

Sanofi to acquire U.S. biotech Inhibrx in $2.2 billion deal

4th of July breaks record for highest global temperature ever measured

explore

focus

focus

focus